These observations, together with the finding that neither genetic Keap1 knockdown nor its pharmacological inactivation by TBE-31 affects adenoma formation, lead us to conclude that in this model, the enhanced metabolic changes conferred by the Keap1 knockdown do not substantially contribute to the early stages of the colorectal carcinogenesis process. This evidence concerns the gene KEAP1 and adenoma.